Erratum: Corrections (The Lancet Infectious Diseases (2012) 12(12) (925–932) (S1473309912702074) (10.1016/S1473-3099(12)70207-4));Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): A multi-site, randomised trial

The Lancet Infectious Diseases

Volumn 12, Issue 12, 2012, Pages 925-932

  Walson, Judd ^a,b   Singa, Benson ^b   Sangaré, Laura ^a   Naulikha, Jaqueline ^a,b   Piper, Benjamin ^a,b   Richardson, Barbra ^a,c   Otieno, Phelgona Apondi ^b   Mbogo, Loice Wangari ^b   Berkley, James A ^d   John Stewart, Grace ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; COTRIMOXAZOLE; PRAZIQUANTEL; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HELMINTHIASIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; KENYA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WORM EXPULSION;

EID: 84869881800     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30220-1     Document Type: Erratum

References (17)

1. Outlook: UNAIDS outlook report 2009, Joint United Nations Programme on HIV/AIDS, Joint United Nations Programme on HIV/AIDS, Geneva, (accessed Sept 4, 2012). http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2009/jc1796_outlook_en.pdf.
2. Global report: UNAIDS report on the global AIDS epidemic 2010, Joint United Nations Programme on HIV/AIDS, Joint United Nations Programme on HIV/AIDS, Geneva, (accessed Sept 4, 2012). http://www.unaids.org/en/media/unaids/contentassets/documentsunaidspublication/2010/20101123_globalreport_en.pdf.
3. Walson JL, Otieno PA, Mbuchi M, et al. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS 2008, 22:1601-1609.
4. Modjarrad K, Vermund SH Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010, 10:455-463.
5. Walson JL, Herrin BR, John-Stewart G Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst Rev 2009, 3. CD006419.
6. Hotez PJ, Fenwick A Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl Trop Dis 2009, 3:e485.
7. de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003, 19:547-551.
8. Global HIV/AIDS response: epidemic update and health sector progress towards universal access 2011 WHO, UNAIDSUNAIDS, UNICEFUNICEF, (accessed Sept 4, 2012). http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20111130_UA_Report_en.pdf.
9. Guidelines for antiretroviral drug therapy in Kenya 2005, National AIDS and STI Control Programme, Ministry of Health, Nairobi. 3rd edn.
10. Basuni M, Muhi J, Othman N, et al. A pentaplex real-time polymerase chain reaction assay for detection of four species of soil-transmitted helminths. Am J Trop Med Hyg 2011, 84:338-343.
11. ten Hove RJ, Verweij JJ, Vereecken K, Polman K, Dieye L, van Lieshout L Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and S haematobium infection in stool samples collected in northern Senegal. Trans R Soc Trop Med Hyg 2008, 102:179-185.
12. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med 1996, 335:1081-1090.
13. MacArthur RD, Novak RM, Peng G, et al. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. Lancet 2006, 368:2125-2135.
14. Lingappa JR, Baeten JM, Wald A, et al. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010, 375:824-833.
15. Preventive chemotherapy in human helminthiasis 2006, WHO, World Health Organization, Geneva, (accessed Sept 4, 2012). http://whqlibdoc.who.int.offcampus.lib.washington.edu/publications/2006/9241547103_eng.pdf.
16. Nielsen NO, Simonsen PE, Dalgaard P, et al. Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial. Am J Trop Med Hyg 2007, 77:507-513.
17. Wolday D, Mayaan S, Mariam ZG, et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr 2002, 31:56-62.